Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OTR-004
- Development stage
- Unknown
- Lead developer
- OTR Therapeutics
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
01
Overview
OTR-004 is a discovery-stage therapeutic candidate being developed by OTR Therapeutics for the treatment of unspecified oncology indications. The drug is based on the company's proprietary ReGeneraTing Agent (RGTA) technology, which utilizes synthetic heparan sulfate mimics to restore and stabilize the extracellular matrix (ECM) microenvironment. RGTAs are chemically substituted dextran polymers (specifically carboxymethyl benzylamide sulfonate dextrans) designed to replace degraded heparan sulfates in the ECM. By binding to and protecting endogenous heparin-binding growth factors and cytokines from proteolytic degradation, OTR-004 aims to modulate the tumor microenvironment and potentially inhibit cancer progression. As of the latest sponsor updates, the specific molecular targets and precise mechanism of action for OTR-004 in oncology remain undisclosed.
Beyond the preview
Go deeper on OTR-004.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OTR-004.